WeVote

Bill

Bill

SB 2757

Alternative Funding Task Force; create from members of the Mississippi Rare Disease Advisory Council.

2025 Regular Session Introduced by Chad McMahan

Mississippi bill establishes task force from rare disease council to study alternative funding mechanisms for rare disease treatment and research in the state.

Died In Committee
0
WeVote Research Nonpartisan
Bill Summary · SB 2757

Legislative bill overview

SB 2757 would establish an Alternative Funding Task Force composed of members from the existing Mississippi Rare Disease Advisory Council. The task force would presumably study and recommend alternative funding mechanisms for rare disease treatment and research in Mississippi, though the bill's specific objectives are not detailed in the available information.

Why is this important

Rare diseases affect relatively small patient populations, making them economically unattractive for pharmaceutical development and creating funding gaps for affected Mississippians. A dedicated task force could identify innovative financing models—such as grants, public-private partnerships, or specialized insurance mechanisms—to improve access to treatments and research for these conditions.

Potential points of contention

  • Unclear scope and authority: The bill doesn't specify what "alternative funding" means or what powers the task force would have to implement recommendations
  • Resource allocation: Creating new task forces requires state resources and staff time; critics may question the cost-benefit versus expanding existing council functions
  • Implementation gap: Even if the task force identifies funding solutions, there's no guarantee the legislature would appropriate funds or pass enabling legislation to implement them
  • Limited population impact: Rare diseases affect small numbers of patients, which could limit political prioritization compared to more prevalent health issues

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.